BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33614241)

  • 21. CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis.
    Dou D; Ren X; Han M; Xu X; Ge X; Gu Y; Wang X; Zhao S
    Cancer Cell Int; 2020; 20():454. PubMed ID: 32944002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1 axis.
    Tao W; Sun W; Zhu H; Zhang J
    Biochem Biophys Res Commun; 2018 Oct; 504(4):629-634. PubMed ID: 30193732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA-HAGLR motivates triple negative breast cancer progression by regulation of WNT2 via sponging miR-335-3p.
    Jin L; Luo C; Wu X; Li M; Wu S; Feng Y
    Aging (Albany NY); 2021 Aug; 13(15):19306-19316. PubMed ID: 34375306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA circ-ZEB1 acts as an oncogene in triple negative breast cancer via sponging miR-448.
    Pei X; Zhang Y; Wang X; Xue B; Sun M; Li H
    Int J Biochem Cell Biol; 2020 Sep; 126():105798. PubMed ID: 32629026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LINC01096 knockdown inhibits progression of triple-negative breast cancer by increasing miR-3130-3p.
    Wang GP; Mou ZL; Xu YY; Liu GX; Wang DM; Zhang HP
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7445-7456. PubMed ID: 31539132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers.
    Mokhlis HA; Bayraktar R; Kabil NN; Caner A; Kahraman N; Rodriguez-Aguayo C; Zambalde EP; Sheng J; Karagoz K; Kanlikilicer P; Abdel Aziz AAH; Abdelghany TM; Ashour AA; Wong S; Gatza ML; Calin GA; Lopez-Berestein G; Ozpolat B
    Mol Ther Nucleic Acids; 2019 Mar; 14():301-317. PubMed ID: 30654191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA dehydrodolichyl diphosphate synthase facilitated triple-negative breast cancer progression via miR-362-3p/DDX5 axis.
    Cui S; Zhang Y; Xing L; Li R; Piao Y; Liu H
    Environ Toxicol; 2022 Jun; 37(6):1483-1494. PubMed ID: 35343646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of miRNA-3613-3p Enhances the Sensitivity of Triple Negative Breast Cancer to CDK4/6 Inhibitor Palbociclib.
    Yu Y; Liao H; Xie R; Zhang Y; Zheng R; Chen J; Zhang B
    Front Oncol; 2020; 10():590813. PubMed ID: 33330073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-129-1-3p Represses the Progression of Triple-Negative Breast Cancer by Targeting the GRIN2D Gene.
    Li Q; Gu Z; Tan Q; Ren L; Chen S
    Biomed Res Int; 2022; 2022():1549357. PubMed ID: 35295962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. USP6NL mediated by LINC00689/miR-142-3p promotes the development of triple-negative breast cancer.
    Ma T; Liu H; Liu Y; Liu T; Wang H; Qiao F; Song L; Zhang L
    BMC Cancer; 2020 Oct; 20(1):998. PubMed ID: 33054738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2.
    Zhao M; Zhang M; Tao Z; Cao J; Wang L; Hu X
    Technol Cancer Res Treat; 2020; 19():1533033820905824. PubMed ID: 32174262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
    Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
    Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-130a-3p blocks Wnt signaling cascade in the triple-negative breast cancer by targeting the key players at multiple points.
    Poodineh J; Sirati-Sabet M; Rajabibazl M; Mohammadi-Yeganeh S
    Heliyon; 2020 Nov; 6(11):e05434. PubMed ID: 33225091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Biological Function of TUSC7/miR-1224-3p Axis in Triple-Negative Breast Cancer.
    Zheng BH; He ZX; Zhang J; Ma JJ; Zhang HW; Zhu W; Shao ZM; Ni XJ
    Cancer Manag Res; 2021; 13():5763-5774. PubMed ID: 34305410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression.
    Mansoori B; Mohammadi A; Ghasabi M; Shirjang S; Dehghan R; Montazeri V; Holmskov U; Kazemi T; Duijf P; Gjerstorff M; Baradaran B
    J Cell Physiol; 2019 Jun; 234(6):9816-9825. PubMed ID: 30480817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p/OTX1 axis.
    Chen FY; Zhou ZY; Zhang KJ; Pang J; Wang SM
    Cancer Cell Int; 2020; 20():508. PubMed ID: 33088216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dihydrotestosterone Induces Chemo-Resistance of Triple-Negative Breast MDA-MB-231 Cancer Cells Towards Doxorubicin Independent of ABCG2 and miR-328-3p.
    Al-Momany B; Hammad H; Ahram M
    Curr Mol Pharmacol; 2021; 14(5):860-870. PubMed ID: 34061013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy.
    Wang S; Zhang J; Wang Y; Chen M
    Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-590-3p inhibits invasion and metastasis in triple-negative breast cancer by targeting Slug.
    Yan M; Ye L; Feng X; Shi R; Sun Z; Li Z; Liu T
    Am J Cancer Res; 2020; 10(3):965-974. PubMed ID: 32266103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.